What factors contribute to uncontrolled gout and hospital admission? A qualitative study of inpatients and their primary care practitioners.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
23 12 2019
Historique:
entrez: 26 12 2019
pubmed: 26 12 2019
medline: 5 11 2020
Statut: epublish

Résumé

To provide deeper insight into why patients are admitted to hospital with gout and discover potential targets for better disease control. Data from semi-structured interviews were analysed using a thematic analysis approach. Eleven inpatients from a tertiary institution in the Australian Capital Territory of Australia and their respective general practitioners (GPs) were invited to participate in the semi-structured interviews. Despite significant pain and disability that accompanied acute flares, patients continue to experience shame in seeking treatment and regarded gout as being not particularly important. Other barriers included patients' poor continuity of care with and lack of confidence in GPs, suboptimal management in outpatient and inpatient settings, poor understanding of disease and treatment, and misconceptions held by both patients and physicians leading to uncontrolled disease activity. Barriers to optimal gout management including patient and health practitioner factors have produced a complex effect which has led to a cycle of treatment avoidance behaviours and recurrent hospitalisations for severe acute gout flares. These barriers could be addressed using a multipronged approach guided by the chronic care model which has been applied in a variety of other chronic diseases with improved patient and professional-level outcomes. Managing gout according to best practice for chronic disease is more likely to prevent recurrent hospitalisations and improve health outcomes in patients with gout.

Identifiants

pubmed: 31874894
pii: bmjopen-2019-033726
doi: 10.1136/bmjopen-2019-033726
pmc: PMC7008429
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e033726

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Rheumatol Int. 2016 Dec;36(12):1753-1758
pubmed: 27770227
Int J Rheum Dis. 2015 Mar;18(3):341-51
pubmed: 25884565
Rheumatology (Oxford). 2007 Sep;46(9):1441-4
pubmed: 17586863
BMC Fam Pract. 2018 Jan 9;19(1):11
pubmed: 29316889
Reumatismo. 2015 Dec 23;67(4):138-48
pubmed: 27215179
Ann Rheum Dis. 2015 Oct;74(10):1789-98
pubmed: 26359487
Ann Rheum Dis. 2012 Sep;71(9):1490-5
pubmed: 22440822
Ann Fam Med. 2017 Nov;15(6):557-560
pubmed: 29133496
Arthritis Rheum. 2007 Jun 15;57(5):822-9
pubmed: 17530682
Rheumatol Int. 2014 Jul;34(7):963-70
pubmed: 24390636
Clin Rheumatol. 2016 Mar;35(3):715-21
pubmed: 25409858
Arthritis Care Res (Hoboken). 2012 Oct;64(10):1447-61
pubmed: 23024029
Rheumatology (Oxford). 2017 Jul 1;56(7):e1-e20
pubmed: 28549177
J Prim Health Care. 2014 Mar 01;6(1):73-8
pubmed: 24624415
J Clin Rheumatol. 2009 Sep;15(6):271-4
pubmed: 19734730
BMC Musculoskelet Disord. 2017 Nov 3;18(1):429
pubmed: 29100504
Milbank Q. 1996;74(4):511-44
pubmed: 8941260
BMJ Qual Improv Rep. 2017 Apr 25;6(1):
pubmed: 28469909
BMC Fam Pract. 2018 May 9;19(1):54
pubmed: 29743018
Arthritis Care Res (Hoboken). 2012 Oct;64(10):1431-46
pubmed: 23024028
Acta Reumatol Port. 2010 Oct-Dec;35(5):466-74
pubmed: 21245815
Arthritis Res Ther. 2018 Jul 11;20(1):143
pubmed: 29996922
BMJ. 2017 Feb 1;356:j84
pubmed: 28148478
J Rheumatol. 2016 Jan;43(1):144-9
pubmed: 26568590
Int J Cardiol. 2018 May 1;258:279-288
pubmed: 29544944
Ann Rheum Dis. 2017 Jan;76(1):29-42
pubmed: 27457514
Arthritis Res Ther. 2015 Jan 23;17:13
pubmed: 25612613
J Rheumatol. 2015 Sep;42(9):1702-7
pubmed: 26233513
Ann Rheum Dis. 2007 Mar;66(3):377-88
pubmed: 17046965
Rheumatology (Oxford). 2018 Jul 1;57(7):1282-1292
pubmed: 29672772
PLoS One. 2018 Feb 8;13(2):e0190852
pubmed: 29420543
Arthritis Res Ther. 2018 Jun 1;20(1):110
pubmed: 29859127
Nat Rev Rheumatol. 2015 Nov;11(11):649-62
pubmed: 26150127
J Clin Rheumatol. 2011 Jan;17(1):1-6
pubmed: 21169857
Ann Rheum Dis. 2015 Apr;74(4):661-7
pubmed: 24431399
Ann Rheum Dis. 2018 Mar;77(3):399-404
pubmed: 29170202
Clin Rheumatol. 2018 Aug;37(8):2291-2296
pubmed: 29721712
Milbank Q. 2012 Jun;90(2):311-46
pubmed: 22709390
Postgrad Med. 2016 Jan;128(1):34-40
pubmed: 26578028
BMJ Open. 2018 Jul 28;8(7):e020626
pubmed: 30056378
Ann Rheum Dis. 2007 Oct;66(10):1311-5
pubmed: 17504843

Auteurs

Darren Chyi Hsiang Kong (DCH)

Department of Rheumatology, Canberra Hospital, Canberra, Australian Capital Territory, Australia darrenkong@outlook.com.

Elizabeth Ann Sturgiss (EA)

Department of General Practice, Monash University, Notting Hill, Victoria, Australia.
School of Population Health, National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australian Capital Territory, Australia.

Annamma Kochummen Dorai Raj (AK)

Department of Rheumatology, Canberra Hospital, Canberra, Australian Capital Territory, Australia.

Kieran Fallon (K)

Department of Rheumatology, Canberra Hospital, Canberra, Australian Capital Territory, Australia.
Faculty of Medicine, College of Health and Medicine, Australian National University, Canberra, Australian Capital Territory, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH